Welcome To The Critical Outcome Technologies Inc HUB On AGORACOM
Our disease Targets > Small cell lung cancer, Multiple sclerosis, HIV Integrase, Colorectal cancer & Adult acute leukemia
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Close

Message: Announces the Issuance of Stock Options

Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »
2nd shots 1 002
Clavis
Rank: [?]
President
Points: [?]
23987
Rating: [?]
Votes: 222 Score: 3.5
  • Currently 3.6/5 Stars.
Your Vote:
Please Log In to Vote
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Announces the Issuance of Stock Options

posted on Feb 18, 09 01:00PM
February 18, 2009
Critical Outcome Technologies Inc. Announces the Issuance of Stock Options
LONDON, ONTARIO--(Marketwire - Feb. 18, 2009) - Critical Outcome Technologies Inc. (TSX VENTURE:COT) announced today, that at its Board meeting of February 17, 2009 the Board of Directors approved the granting of 422,389 stock options to its nine Directors under the Company's Stock Option Plan as a retainer for their service on the Board and its committees during fiscal 2009. The options vest immediately, have a life of five years and are exercisable at a price of $0.90 per share. The exercise price represents the closing price of the Company's common shares on February 12, 2009, the last trade reported on the TSX Venture Exchange prior to the meeting date.

"The use of stock options to compensate the board members allows us to conserve our cash as we move forward with our drug development plans and demonstrates the Directors' belief and commitment to the company's future," advised company Chairman, Mr. John Drake.

About Critical Outcome Technologies Inc. (COTI)

COTI is formed around a unique computational platform technology called CHEMSAS(R), which allows for the accelerated identification, profiling and optimization of targeted small molecules potentially effective in the treatment of human diseases for which current therapy is either lacking or ineffective. COTI's business is focused on the discovery and preclinical development of libraries of novel, optimized lead molecules for the treatment of specific cancers, HIV and multiple sclerosis. Currently, five targeted libraries of lead compounds are under active development: small cell lung cancer, HIV integrase inhibitors, acute adult leukemia, multiple sclerosis and colorectal cancer.
Reply New Message
« Prev Message Back To Forum Go to Threaded View Next Message »

New Message

Please login to post a reply

Agoracom TV
Check out Agoracom's daily, fast-paced, newscast on the morning's top Small-Cap newsmakers
Featured News
Get top news releases from the Small-Cap world
Blog
Follow George Tsiolis's Small-Cap and Micro-Cap 2.0 Blog

Mesh With Us On The Web's Top Social Networking Sites

YouTube Facebook Twitter Picasa LinkedIn FriendFeed iTunes

Find Our Content Throughout The Web With Our New Media Partners

RIM AOL Yahoo ReportonBusiness

AGORACOM Quick Tips

AGORACOM 100 - The Top 100 Small Caps ... Find Your Next Investment
Click To Watch Today's Show

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote

Open COT:CA Stock Quote

Investment Ideas

Like Critical Outcome Technologies Inc? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.
  • Developer of the TERRASTARTM in-flight safety monitoring system
  • The first system in the world to feature real-time in-flight data monitoring and diagnostics
  • echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS

Hub Leaders

2nd shots 1 002
Clavis